Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8739104 | International Journal of Infectious Diseases | 2018 | 35 Pages |
Abstract
HBV seroprevalence among PWID was about five times higher than in the general population in Germany, confirming PWID as an important risk group. Targeted information campaigns on HBV and HBV prevention for PWID and professionals in contact with PWID need to be intensified. Routinely offered HBV vaccination during imprisonment and opioid substitution therapy would likely improve vaccination rates among PWID.
Related Topics
Life Sciences
Immunology and Microbiology
Applied Microbiology and Biotechnology
Authors
J.M. Haussig, S. Nielsen, M. Gassowski, V. Bremer, U. Marcus, B. Wenz, N. Bannert, C.T. Bock, R. Zimmermann, on behalf of the DRUCK study group on behalf of the DRUCK study group,